Publications by authors named "Michael Rivner"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

4,422

Total Likes

586

Extended Reach

14,226

Social Features

40
B
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.
Tuan Vu, Hacer Durmus, Michael Rivner, Sheetal Shroff, Thomas Ragole

Nat Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALSUntangled #80: ISRIB (Integrated stress response InhiBitor).
Javier Mascias Cadavid, Anna Mena Bravo, Paul Barkhaus, Benjamin Barnes, Michael Benatar, Michael Rivner

Amyotroph Lateral Scler Frontotemporal Degener· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis.
Brooke Krivickas, Erica Scirocco, Elisa Giacomelli, Saloni Sharma, Molly Benson, Michael Rivner

Muscle Nerve· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial.
Vera Bril, Tomasz Berkowicz, Andrzej Szczudlik, Michael W Nicolle, Josef Bednarik, Michael Rivner

Muscle Nerve· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.
Steven Perrin, Shafeeq Ladha, Nicholas Maragakis, Michael H Rivner, Jonathan Katz

PLoS Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.
Luis Querol, Jérôme De Sèze, Tina Dysgaard, Todd Levine, T Hemanth Rao, Michael Rivner

J Neurol Neurosurg Psychiatry· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis.
Zheng Yu, Meiying Zhang, Hongyang Jing, Peng Chen, Rangjuan Cao, Michael H Rivner

Neurology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial.
Michael D Weiss, Eric A Macklin, Courtney E McIlduff, Steve Vucic, Brian J Wainger, Michael H Rivner

Muscle Nerve· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Brian J Wainger, Eric A Macklin, Steve Vucic, Courtney E McIlduff, Sabrina Paganoni, Michael H Rivner

JAMA Neurol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NEALS primary lateral sclerosis registry.
Sabrina Paganoni, Fabiola De Marchi, James Chan, Sara K Thrower, Nathan P Staff, Michael Rivner

Amyotroph Lateral Scler Frontotemporal Degener· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study.
Michael H Rivner, Brandy M Quarles, Jin-Xiu Pan, Zheng Yu, James F Howard

Muscle Nerve· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Ikjae Lee, Hui-Chien Kuo, Inmaculada B Aban, Gary R Cutter, Tarrant McPherson, Michael H Rivner

Neurology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, Greg Minisman, Hui-Chien Kuo, Michael H Rivner

Lancet Neurol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
Michael H Rivner, Mamatha Pasnoor, Mazen M Dimachkie, Richard J Barohn, Lin Mei

Neurol Clin· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice.
Min Yan, Ziyang Liu, Erkang Fei, Wenbing Chen, Xinsheng Lai, Michael H Rivner

Neuroscience· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability.
James D Berry, Sabrina Paganoni, Nazem Atassi, Eric A Macklin, Namita Goyal, Michael Rivner

Muscle Nerve· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
Isabell Cordts, Nicolas Bodart, Kathi Hartmann, Katerina Karagiorgou, John S Tzartos, Michael H Rivner

J Neurol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients.
Michael H Rivner, Siyang Liu, Brandy Quarles, Brandi Fleenor, Chengyong Shen

Muscle Nerve· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Sulfoglucuronosyl Paragloboside Antibody: A Potential Serologic Marker of Amyotrophic Lateral Sclerosis.
Dongpei Li, Seigo Usuki, Brandy Quarles, Michael H Rivner, Toshio Ariga

ASN Neuro· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Thymectomy in Myasthenia Gravis.
Gil I Wolfe, Henry J Kaminski, Inmaculada B Aban, Greg Minisman, Hui-Chien Kuo, Michael H Rivner

N Engl J Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis.
Terence E Ryan, Melissa L Erickson, Ajay Verma, Juan Chavez, Michael H Rivner

Muscle Nerve· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples.
Seigo Usuki, Dawn O'Brien, Michael H Rivner, Robert K Yu

J Immunol Methods· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALS Untangled No. 20: the Deanna protocol.

Amyotroph Lateral Scler Frontotemporal Degener· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of radiculopathies in motor vehicle accidents.
Randall L Braddom, Lawrence Spitz, Michael H Rivner

Muscle Nerve· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis